FI945458A0 - Parannettuja antiandrogeenejä - Google Patents

Parannettuja antiandrogeenejä

Info

Publication number
FI945458A0
FI945458A0 FI945458A FI945458A FI945458A0 FI 945458 A0 FI945458 A0 FI 945458A0 FI 945458 A FI945458 A FI 945458A FI 945458 A FI945458 A FI 945458A FI 945458 A0 FI945458 A0 FI 945458A0
Authority
FI
Finland
Prior art keywords
antiandrogens
androgen
improved
treatment
dependent diseases
Prior art date
Application number
FI945458A
Other languages
English (en)
Swedish (sv)
Other versions
FI945458A (fi
Inventor
Fernand Labrie
Yves Merand
Shankar M Singh
Original Assignee
Endrorecherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endrorecherche Inc filed Critical Endrorecherche Inc
Publication of FI945458A0 publication Critical patent/FI945458A0/fi
Publication of FI945458A publication Critical patent/FI945458A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI945458A 1993-05-17 1994-11-21 Parannettuja antiandrogeenejä FI945458A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6061293A 1993-05-17 1993-05-17
PCT/CA1993/000216 WO1994026767A1 (en) 1993-05-17 1993-05-20 Improved antiandrogens

Publications (2)

Publication Number Publication Date
FI945458A0 true FI945458A0 (fi) 1994-11-21
FI945458A FI945458A (fi) 1995-01-16

Family

ID=22030624

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945458A FI945458A (fi) 1993-05-17 1994-11-21 Parannettuja antiandrogeenejä

Country Status (14)

Country Link
EP (1) EP0650495B1 (fi)
JP (1) JP2741286B2 (fi)
KR (1) KR100241228B1 (fi)
AT (1) ATE197458T1 (fi)
CA (1) CA2136303A1 (fi)
CZ (2) CZ285893B6 (fi)
DE (1) DE69329649D1 (fi)
FI (1) FI945458A (fi)
HU (1) HUT69408A (fi)
PL (1) PL307333A1 (fi)
RU (1) RU2141966C1 (fi)
SK (1) SK139194A3 (fi)
TW (1) TW259791B (fi)
WO (1) WO1994026767A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
MXPA00008868A (es) 1998-03-11 2003-04-25 Endorech Inc Inhibidores de dihidrogenasa de 17 -hidroxiesteroide y metodos para su uso.
WO2002089802A2 (en) 2001-05-08 2002-11-14 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
CN1551878B (zh) 2001-09-06 2011-08-10 先灵公司 用于治疗雄激素依赖性疾病的3型17β-羟基类固醇脱氢酶抑制剂
PE20030705A1 (es) 2001-10-17 2003-08-21 Schering Corp Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes
EP1467739A4 (en) * 2002-01-15 2008-01-09 Merck & Co Inc 17-HYDROXY-4-AZA-ANDROSTAN-3-ONE AS ANDROGEN RECEPTOR MODULATORS
JP4614770B2 (ja) 2002-11-18 2011-01-19 シェーリング コーポレイション アンドロゲン依存性疾患を処置するための１７β−ヒドロキシステロイドデヒドロゲナーゼタイプ３インヒビター
ES2312845T3 (es) 2002-12-17 2009-03-01 Schering Corporation Inhibidores de la deshidrogenasa de 17 beta-hidroxiesteroides de tipo 3 para el tratamiento de enfermedades dependientes de androgenos.
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1081494A (en) * 1965-09-14 1967-08-31 British Drug Houses Ltd 17ª‡-(alka-1',3'-diynyl)-steroids
US3875188A (en) * 1968-04-10 1975-04-01 Eugene E Galantay 17-Beta-alpha-lower alkyl allene-substituted steroids
FR2430952A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives acetyleniques de l'androst 4-ene, leur procede de preparation et leur application comme medicament
JPS5513273A (en) * 1978-07-13 1980-01-30 Kanebo Ltd Readily absorbable thiazolidine prodrug of anti- inflammatory corticosteroid and its drug composition
EP0485392B1 (en) * 1989-07-07 1998-09-09 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity

Also Published As

Publication number Publication date
CA2136303A1 (en) 1994-11-24
DE69329649D1 (de) 2000-12-14
WO1994026767A1 (en) 1994-11-24
RU2141966C1 (ru) 1999-11-27
ATE197458T1 (de) 2000-11-11
KR100241228B1 (ko) 2000-02-01
RU94046463A (ru) 1997-02-27
CZ282494A3 (en) 1995-12-13
JP2741286B2 (ja) 1998-04-15
JPH08510988A (ja) 1996-11-19
CZ285893B6 (cs) 1999-11-17
FI945458A (fi) 1995-01-16
TW259791B (fi) 1995-10-11
CZ287991B6 (cs) 2001-03-14
EP0650495A1 (en) 1995-05-03
SK139194A3 (en) 1995-07-11
HUT69408A (en) 1995-09-28
PL307333A1 (en) 1995-05-15
EP0650495B1 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
SE9604786D0 (sv) New compounds
BG102600A (en) Carbamoyloxy derivatives of mutilin and their use as bactericides
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
IT1285770B1 (it) Composti corticoidei
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
DK0765320T3 (da) Benzimidazolonderivater med central dopaminerg aktivitet
HU9301197D0 (en) Medical preparatives containing quinoline and quinazoline derivatives as well as new quinoline and quinazoline derivatives
DE69329649D1 (de) Verbesserte antiandrogene
DE3585980D1 (de) Hydrazinderivate und ihre verwendung.
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
FI970469A (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
CA2256514A1 (en) Veterinary use of a pleuromutilin derivative
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
KR970702869A (ko) 항종양성 인돌로피롤로카르바졸 유도체(antitumor indolopyprolocarbazole derivative)
ATE54912T1 (de) Mevalonolactonaehnliche imidazole und derivate.
SU1774617A1 (ru) Производные 3-хлор-1,4-нафтохинона, обладающие бактерицидными и фунгицидными свойствами